Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (28993)	6/28/1999 12:42:00 PM
From: Mudcat	Read Replies (2) \| Respond to of 32384

Hey you asked me to provide documentation from Ligand and I gave it to you. I'm not surprised your trying to spin your way out of this, its your MO as everyone on this board knows. I provided the documentation just like I said I would and the slips are even worse than I first predicted. One report said both NDA's in 1998, the other report said both NDA's in the second half (Jul-Dec 98)of 1998. Let's use the second half 1998 to early 1999 estimate as the baseline: Oral Targretin is then late from 3-11 months(calculated by using either Jul98 or Mar99 as the starting estimate), Targretin gel is late from 3 - 12 months and still counting. The baseline is what your measured against when figuring a slip, not your latest estimate. You can never have a slip if you schedule the way you do (where you use the revised estimate as the baseline). Try reading some Project Management books.